From: Optimization of adefovir therapy in chronic hepatitis B according to baseline predictors and on-treatment HBV DNA: a 5-Year prospective study
variables
Age in years, mean ± SD
31.7 ± 6.6
Male, %
85.1%
HBV genotype C, %
100%
Baseline ALT, IU/L
216.3 ± 169.7
Baseline HBV DNA(log10copies/ml)
8.5 ± 0.8
Baseline HBeAg(log10)
2.8 ± 0.4
BaselineHBsAg(log10)
3.7 ± 0.5